Table 1 Patient backgrounds

From: Elevated pulse amplification in hypertensive patients with advanced kidney disease

CKD stages

1

2

3a

3b

4

5

Patient number

211

1051

430

152

71

105

Age (y/o)

59

65*

68*

69*

65*

62

Sex (male, %)

50

56

53

52

66

59

Diabetes (%)

28

26

28

28

30

33

Dyslipidemia (%)

41

48

52

54

37

37

Height (cm)

159

159

159

159

160

159

Weight (kg)

62

62

63

61

59*

58*

VD (class)

1.47

1.50

1.59

1.84*

1.93*

2.17*

NVD (class)

0.41

0.44

0.77*

0.85*

0.62*

0.71*

SBP (mmHg)

138

136

134*

133*

135*

140

DBP (mmHg)

81

76*

74*

72*

73*

73*

PP (mmHg)

57

59

59

61*

62*

68*

SBP2 (mmHg)

127

125

124

122

123

127

PP2 (mmHg)

46

48

49*

51*

50*

55*

PR (bpm)

74

70*

68*

68*

70*

72

Pulse amplification

1.27

1.27

1.25

1.24

1.25

1.29

  1. Age, weight, vasodilator (VD), non-vasodilator antihypertensives (NVD), blood pressures, and pulse rate (PR) differed among six groups. For the other abbreviations see text. Asterisk indicates significant difference from stage 1. Only mean values were expressed for clarity
Back to article page